Gapping down
In reaction to disappointing earnings/guidance:
- TUFN -26.8% (lowers revenue and operating profit guidance for Q4), BBBY -11.1% (also suspends full year guidance), GMED -6% (guides Q4 revs slightly above but FY20 guidance below), KSS -5.8%, SMPL -4.8%, LB -4.6%, JCP -3.3%, HUM -0.5%
Select metals/mining stocks trading lower:
- BBL -1.2%, SLV -1%, BHP -0.6%, RIO -0.6%, GDX -0.5%
Other news:
- IPHA -7.6% (provided update from regulatory agencies on Lacutamab TELLOMAK trial)
- MRTX -5.5% (files for $250 mln share common stock offering)
- AMAG -5.2% (CEO William Heiden plans to step down, announces results of strategic review, provides downside FY 20 revs guidance)
- TPVG -5% (priced offering of 5 mln shares of common stock)
- OSMT -3.7% (prices 6 mln shares at $5.00/share)
Analyst comments:
- FATE -3.1% (downgraded to Market Perform from Outperform at BMO Capital Markets)
- DXC -1.5% (downgraded to Underweight from Equal Weight at Wells Fargo)
- ADM -1.4% (downgraded to Sell at Monness Crespi & Hardt)
- EXLS -1.2% (downgraded to Underweight from Equal Weight at Wells Fargo)
- EBAY -1.1% (downgraded to Underperform from Hold at Jefferies)
- MANT -0.9% (downgraded to Underweight from Equal Weight at Wells Fargo)
- LITE -0.6% (downgraded to Neutral from Buy at UBS)